AI-designed universal coronavirus vaccine passes first human trial
A new universal coronavirus vaccine, designed using artificial intelligence, has successfully completed its first human trial, showing promising results.
Why it matters
This development could revolutionize the way we approach vaccinations for COVID-19 and other coronaviruses, potentially providing broader immunity.
Details
The vaccine aims to target multiple strains of the virus, which could lead to more effective and long-lasting protection.
Sources